Apolipoprotein B/Apolipoprotein A ratio: a novel prognostic factor for pancreatic cancer

Author:

Li Chenxi1,yang xuhui1,Zhong Yan1,Wang Wenying1,Jin Xin1,Bian Lihua1,wang xiaona1

Affiliation:

1. Chinese PLA General Hospital

Abstract

Abstract Objective: The relationship between serum lipids and prognosis of pancreatic cancer has not been confirmed. Our purpose in the study was to investigate the associations between serum lipids level and prognosis in patients with pancreatic cancer. Methods: A retrospective study was performed on 286 pancreatic cancer patients who admitted to our hospital from January 1, 2017 to December 31, 2021. Serum lipids level were recorded. Clinical-pathological characteristics, oncologic outcomes, progression free survival (PFS) and overall survival (OS) were collected. The prognostic significance was determined by Kaplan-Meier analysis and Cox proportional hazards regression model. Results: Regarding serum lipids level, compared to normal apolipoprotein B/ apolipoprotein A (ApoB/ApoA), high ApoB/ApoA level indicated a shorter OS (HR:2.028, 95% CI: 1.174-2.504, P = 0.011) and a shorter PFS (HR:1.800, 95% CI: 1.076-3.009, P = 0.025). Other serum lipid molecules were not associated with PFS and OS. Conclusion: ApoB/ApoA might be an independent prognostic factor of pancreatic cancer.

Publisher

Research Square Platform LLC

Reference45 articles.

1. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors;Klein AP;Nat Rev Gastroenterol Hepatol

2. Association between cholesterol intake and pancreatic cancer risk: evidence from a meta-analysis;Chen H;Sci Rep

3. Postoperative high-density lipoprotein cholesterol level: an independent prognostic factor for gastric cancer;Li C;Front Oncol

4. Association of cholesterol with risk of pancreatic cancer: a meta-analysis;Wang J;World J Gastroenterol

5. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers;Chun YS;Ann Surg Oncol

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3